Investments
7Portfolio Exits
3About Peierls Foundation
The Peierls Foundation is dedicated to supporting higher education, international relief and programs benefiting children/youth, services and civil rights. It also contributes to national organizations that focus on health, medical research, immigrants, reproductive health and family planning.

Want to inform investors similar to Peierls Foundation about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Peierls Foundation News
May 15, 2019
ArcherDX, Inc. , a Boulder, Colo.-based molecular technology company dedicated to developing solutions that advance the application of personalized genomic medicine, closed an up to $60m Series B financing round. The round was led by Perceptive Advisors, with participation from existing investors PBM Capital, Boulder Ventures, Longwood Fund and Peierls Foundation. The company intends to use the funds to scale operations, advance its companion diagnostic program that spans solid tumors, hematological malignancies and circulating tumor DNA (ctDNA) applications, and expand its minimal residual disease monitoring program accelerating access to a greater than $20 billion worldwide market opportunity. Led by Jason Myers, co-founder and chief executive officer, ArcherDX has developed a liquid biopsy-based minimal residual disease monitoring solution that combines Anchored Multiplex PCR (AMPTM) chemistry with a proprietary algorithm to construct optimal patient-specific assays that are intended to be used to monitor disease and detect progression or recurrence earlier than current standard of care testing. The company plans to develop the assay as a decentralized or kitted in vitro diagnostic solution for global regulatory clearance, with the intention of improving test result turn-around time and lowering per patient testing costs. To date, ArcherDX has raised up to $95m in financing. FinSMEs
Peierls Foundation Investments
7 Investments
Peierls Foundation has made 7 investments. Their latest investment was in ArcherDx as part of their Series B on May 5, 2019.

Peierls Foundation Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/15/2019 | Series B | ArcherDx | $60M | No | 5 | |
3/20/2018 | Series A | |||||
3/15/2011 | Series B | |||||
8/8/2008 | PIPE - II | |||||
6/8/2007 | PIPE - II |
Date | 5/15/2019 | 3/20/2018 | 3/15/2011 | 8/8/2008 | 6/8/2007 |
---|---|---|---|---|---|
Round | Series B | Series A | Series B | PIPE - II | PIPE - II |
Company | ArcherDx | ||||
Amount | $60M | ||||
New? | No | ||||
Co-Investors | |||||
Sources | 5 |
Peierls Foundation Portfolio Exits
3 Portfolio Exits
Peierls Foundation has 3 portfolio exits. Their latest portfolio exit was ArcherDx on June 22, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/22/2020 | Acquired - II | 13 | |||
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.